Table 3 Five-year overall survival & five-year disease free survival of the breast cancer study population
|  | 5-year overall survival (p = 0.000) | 5-year disease free survival (p = 0.000) | ||||||
|---|---|---|---|---|---|---|---|---|
Caucasian | African American | Caucasian | African American | |||||
AJCC-7th Ed | AJCC -8th Ed | AJCC-7th Ed | AJCC -8th Ed | AJCC-7th Ed | AJCC -8th Ed | AJCC-7th Ed | AJCC - 8th Ed | |
Stage IA | 91.7% | 100.0% | 92.5% | 88.4% | 22.0% | 31.1% | 30.1% | 29.7% |
Stage IB | .. | 92.9% | .. | 100.0% | .. | 31.9% | .. | 49.2% |
Stage IIA | 73.3% | 58.3% | 88.2% | 88.9% | 54.9% | 28.6% | 30.7% | 23.3% |
Stage IIB | 66.7% | 51.4% | 96.9% | 83.3% | 0.00% | 31.1% | 25.1% | 0.00% |
Stage IIIA | 64.3% | .. | 78.0% | 93.3% | 40.0% | _ | 59.2% | 24.2% |
Stage IIIB | 85.9% | 66.7% | 59.8% | 74.0% | 55.6% | 33.3% | 68.6% | 42.6% |
Stage IIIC | 0.00% | 80.0% | 48.8% | 68.1% | 0.00% | 27.3% | 13.4% | 45.5% |
Stage IV | 37.5% | 30.0% | 31.3% | 66.7% | 0.00% | 0.00% | 0.00% | 0.00% |